RE:RE:The investors who participated in the PP.....MarketMoney wrote: Is anyone else refreshing SEDAR and tsx szls page once in a while....haha this time I want to make sure I don't miss the opportunity to buy extra discount shares before the rest realize what happen :-)
Yes, for a stock thats the most watched Healthcare one on SH, it is certainly slow moving vis a vis buying. I get the feeling that most investors are waiting for the spike up so they can jump in at that time at a slightly higher price but at least assured that its heading in the right direction. The problem over the past few years was Tripp's overly enthusiastic speculations read: $30 million by years end etc and now investors once burned, want to see concrete numbers and material NRs to back up any claims. There is obviously some doubt in the minds of some as far as Aristotle is concerned - will it have the impact we all think it will, will it be accepted and embraced immediately as a medical break through, will hospitals and medical networks endorse it out of the gate, Oncore etc. etc. If otherwise, investors would be scooping up shares now at seemingly low prices as it sits on the cusp of being announced.
All this to say that as a long I am optimistic that liquid biopsy cancer testing will have a strong market impact and that our Covid testing network is perfectly timed to assist Aristotle - the dominos have lined up well for us marketing wise positioning Aristotle better than if ever would have been without Covid. I guess we are about to find out shortly - bring on that hospital affiliation Clarus alluded to and get the ball rolling - we are definitely overdue for something from Tripp other than of the closing pp variety.